Patents by Inventor Bernard LAUGHLIN

Bernard LAUGHLIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYNERGISTIC FORMULATIONS OF ADENOSINE RECEPTOR MODULATING AGENTS AND ANTICHOLINERGICS
    Publication number: 20240245715
    Abstract: The present disclosure provides a pharmaceutical composition comprising i) an A1 adenosine receptor (A1AR) agonist, ii) an A1AR antagonist, and iii) an anticholinergic. Kits utilizing i) an A1 adenosine receptor (A1AR) agonist, ii) an A1AR antagonist, and iii) an anticholinergic are also provided, as well as methods utilizing the described pharmaceutical compositions and kits.
    Type: Application
    Filed: February 15, 2024
    Publication date: July 25, 2024
    Inventors: Bernard LAUGHLIN, Kelly DREW
  • Synergistic formulations of adenosine receptor modulating agents and anticholinergics
    Patent number: 11911408
    Abstract: The present disclosure provides a pharmaceutical composition comprising i) an A1 adenosine receptor (A1AR) agonist, ii) an A1AR antagonist, and iii) an anticholinergic. Kits utilizing i) an A1 adenosine receptor (A1AR) agonist, ii) an A1AR antagonist, and iii) an anticholinergic are also provided, as well as methods utilizing the described pharmaceutical compositions and kits.
    Type: Grant
    Filed: March 11, 2022
    Date of Patent: February 27, 2024
    Assignee: UNIVERSITY OF ALASKA FAIRBANKS
    Inventors: Bernard Laughlin, Kelly Drew
  • SYNERGISTIC FORMULATIONS OF ADENOSINE RECEPTOR MODULATING AGENTS AND ANTICHOLINERGICS
    Publication number: 20220288099
    Abstract: The present disclosure provides a pharmaceutical composition comprising i) an A1 adenosine receptor (A1AR) agonist, ii) an A1AR antagonist, and iii) an anticholinergic. Kits utilizing i) an A1 adenosine receptor (A1AR) agonist, ii) an A1AR antagonist, and iii) an anticholinergic are also provided, as well as methods utilizing the described pharmaceutical compositions and kits.
    Type: Application
    Filed: March 11, 2022
    Publication date: September 15, 2022
    Inventors: Kelly DREW, Bernard LAUGHLIN